A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/00 (2006.01) A61K 31/06 (2006.01) A61K 31/155 (2006.01) A61K 31/198 (2006.01) A61K 31/341 (2006.01) A61K 31/351 (2006.01) A61K 31/39 (2006.01) A61K 31/403 (2006.01) A61K 31/4439 (2006.01) A61K 31/70 (2006.01) A61K 31/7004 (2006.01) A61K 31/7008 (2006.01) A61P 3/06 (2006.01) A61P 3/08 (2006.01) A61P 3/10 (2006.01)
Patent
CA 2751834
The invention relates to a pharmaceutical composition according to the claim 1 comprising an SGLT2 inhibitor, a DPPIV inhibitor and a third antidiabetic agent which is suitable in the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
L'invention porte sur une composition pharmaceutique selon la revendication 1, contenant un inhibiteur SGLT2, un inhibiteur DPP IV et un troisième agent antidiabétique approprié pour le traitement ou la prévention d'un ou plusieurs états parmi le diabète sucré de type 1, le diabète sucré de type 2, une intolérance au glucose et l'hyperglycémie. De plus, la présente invention porte sur des méthodes de prévention ou de traitement de troubles métaboliques et d'états pathologiques apparentés.
Broedl Uli
Eickelmann Peter
Grempler Rolf
Mark Michael
Seman Leo John
Boehringer Ingelheim International Gmbh
Fetherstonhaugh & Co.
LandOfFree
Pharmaceutical composition comprising a sglt2 inhibitor, a... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition comprising a sglt2 inhibitor, a..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising a sglt2 inhibitor, a... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1723313